PenguinMan/ARXIV huggingface dataset:
Myeloid cell and transcriptome signatures associated with inflammation resolution in a model of self-limiting acute brain inflammation
Authors: Davies, C. L.; Patir, A.; McColl, B. W.
Category: neuroscience
Date: 2018-12-04

Inflammation contributes to tissue repair and restoration of function after infection or injury. However, some forms of inflammation can cause tissue damage and disease, particularly if inappropriately activated, excessive, or not resolved adequately. The mechanisms that prevent excessive or chronic inflammation are therefore important to understand. This is particularly important in the central nervous system where some effects of inflammation can have particularly harmful consequences, including irreversible damage. An increasing number of neurological disorders, both acute and chronic, and their complications are associated with aberrant neuroinflammatory activity.\n\nHere we describe a model of self-limiting acute brain inflammation optimised to study mechanisms underlying inflammation resolution. Inflammation was induced by intracerebral injection of lipopolysaccharide (LPS) and the temporal profile of key cellular and molecular changes were defined during the progression of the inflammatory response. The kinetics of accumulation and loss of neutrophils in the brain enabled well demarcated phases of inflammation to be operatively defined, including induction and resolution phases. Microglial reactivity and accumulation of monocyte-derived macrophages were maximal at the onset of and during the resolution phase. We profiled the transcriptome-wide gene expression changes at representative induction and resolution timepoints and used gene coexpression network analysis to identify gene clusters. This revealed a distinct cluster of genes associated with inflammation resolution that were induced selectively or maximally during this phase and indicated an active programming of gene expression that may drive resolution as has been described in other tissues. Induction of gene networks involved in lysosomal function, lipid metabolism and a comparative switch to MHC-II antigen presentation (relative to MHC-I during induction) were prominent during the resolution phase. The restoration and/or further induction of microglial homeostatic signature genes was notable during the resolution phase.\n\nWe propose the current model as a tractable reductionist system to complement more complex models for further understanding how inflammation resolution in the brain is regulated and as a platform for in vivo testing/screening of candidate resolution-modifying interventions. Our data highlight how resolution involves active cellular and transcriptome reprogramming and identify candidate gene networks associated with resolution-phase adaptations that warrant further study.
Cortico-genetic mapping links individual brain maturity in youths to cognitive and psychiatric traits
Authors: Kaufmann, T.; van der Meer, D.; Alnaes, D.; Frei, O.; Smeland, O. B.; Andreassen, O. A.; Westlye, L. T.
Category: neuroscience
Date: 2018-12-04

Neurodevelopmental trajectories are shaped by interactions between coordinated biological processes and individual experiences throughout ontogeny, yet the specific genetic and environmental impact on brain development is enigmatic. Here, we map the genetic architectures of cognitive traits and psychiatric disorders onto the brain, show that such canonical genetic maps are associated with individual normative patterns in youths, and provide evidence that trauma exposure and parental education may alter this relationship.
Oral thermosensing by murine trigeminal neurons:modulation by capsaicin, menthol, and mustard oil
Authors: Leijon, S. C. M.; Neves, A. F.; Simon, S. A.; Chaudhari, N.; Roper, S.
Category: neuroscience
Date: 2018-12-04

When consumed with foods, mint, mustard and chili peppers generate pronounced oral thermosensations. Here we recorded responses in mouse trigeminal ganglion neurons to investigate interactions between thermal sensing and the active ingredients of these plants -- menthol, allyl isothiocyanate (AITC), and capsaicin, respectively -- at concentrations found in foods and commercial hygiene products. We carried out in vivo confocal calcium imaging of trigeminal ganglia in which neurons express GCaMP3 or GCAMP6s and recorded their responses to oral stimulation with thermal and the above chemesthetic stimuli. In the V3 (oral sensory) region of the ganglion, thermoreceptive neurons accounted for [~]10% of imaged neurons. We categorized them into 3 distinct classes: cool-responsive and warm-responsive thermosensors, and nociceptors (responsive only to temperatures [&ge;]43-45{degrees}). Menthol, AITC, and capsaicin also elicited robust calcium responses that differed markedly in their latencies and durations. Most of the neurons that responded to these chemesthetic stimuli were also thermosensitive. Capsaicin and AITC increased the numbers of warm-responding neurons and shifted the nociceptor threshold to lower temperatures. Menthol attenuated the responses in all classes of thermoreceptors. Our data show that while individual neurons may respond to a narrow temperature range (or even bimodally), taken collectively, the population is able to report on graded changes of temperature. Our findings also substantiate an explanation for the thermal sensations experienced when one consumes pungent spices or mint.\n\nKey points summaryO_LIOrosensory thermal trigeminal afferent neurons respond to cool, warm, and nociceptive hot temperatures with the majority activated in the cool range.\nC_LIO_LIMany of these thermosensitive trigeminal orosensory afferent neurons also respond to capsaicin, menthol and/or mustard oil (allyl isothiocyanate, AITC) at concentrations found in foods and spices.\nC_LIO_LIThere is significant but incomplete overlap between afferent trigeminal neurons that respond to heat and to the above chemesthetic compounds.\nC_LIO_LICapsaicin sensitizes warm trigeminal thermoreceptors and orosensory nociceptors; menthol attenuates cool thermoresponses.\nC_LI
Galectin-3, A Novel Endogenous Trem2 Ligand, Regulates Inflammatory Response and Aβ Fibrilation in Alzheimer’s Disease
Authors: Boza Serrano, A.; Ruiz, R.; Sanchez Varo, R.; Yang, Y.; Garcia-Revilla, J.; Paulus, A.; Jimenez Ferrer, I.; The Netherland Brain,  ; Wennstrom, M.; Vilalta, A.; Dunning, C.; Davila, J. C.; Allendorf, D.; Swanberg, M.; Stegmayr, J.; Jimenez, S.; Roca-Ceballos, M. A.; Navarro-Garrido, V.; L. Hsieh, C.; Miguel-Real, L.; Englund, E.; Linse, S.; Leffler, H.; J. Nilsson, U.; Gutierrez, A.; Brown, G. C.; Vitorica, J.; Venero, J. L.; Deierborg, T.
Category: neuroscience
Date: 2018-12-04

Alzheimers disease (AD) is a progressive neurodegenerative disease in which the formation of extracellular aggregates of amyloid beta (A{beta}) peptide, intraneuronal tau neurofibrillary tangles and microglial activation are major pathological hallmarks. One of the key molecules involved in microglial activation is galectin-3 (gal3), and we demonstrate here for the first time a key role of gal3 in AD pathology. Gal3 was highly upregulated in the brains of AD patients and 5xFAD (familial Alzheimers disease) mice, and found specifically expressed in microglia associated with A{beta} plaques. Single nucleotide polymorphisms in the LGALS3 gene, which encodes gal3, were associated to an increased risk of AD. Gal3 deletion in 5xFAD mice attenuated microglia-associated immune responses, particularly those associated with TLR and TREM2/DAP12 signaling. In vitro data demonstrated the requirement of gal3 to fully activate microglia in response to fibrillar A{beta}. Gal3 deletion decreased the A{beta} burden in 5xFAD mice and improved cognitive behavior. Electron microscopy of gal3 in AD mice demonstrated i) a preferential expression of gal3 by plaque-associated microglia, ii) its presence in the extracellular space and iii) its association to A{beta} plaques. Low concentrations (1 nM) of pure gal3 promoted cross-seeding fibrilization of pure A{beta}. Importantly, a single intrahippocampal injection of gal3 along with A{beta} monomers in WT mice was sufficient to induce the formation of insoluble A{beta} aggregates that were absent when gal3 was lacking. High-resolution microscopy (STORM) demonstrated close co-localization of gal3 and TREM2 in microglial processes, and a direct interaction was shown by a fluorescence anisotropy assay involving the gal3 CRD domain. Furthermore, gal3 stimulated the TREM2-DAP12 signaling pathway. In conclusion, we provide evidence that gal3 is a central regulator of microglial immune response in AD. It drives proinflammatory activation and A{beta} aggregation, as well as acting as an endogenous ligand to TREM2, a key receptor driving microglial response under disease conditions. Gal3 inhibition may, hence, be a potential pharmacological approach to counteract AD.
Attenuation of Aβ-associated hyperactivity reduces Aβ and tau pathology along the entorhinal cortex-hippocampal network
Authors: Rodriguez, G. A.; Barrett, G. M.; Duff, K. E.; Hussaini, A.
Category: neuroscience
Date: 2018-12-04

High levels of the amyloid-beta (A{beta}) peptide have been shown to disrupt neuronal function and induce hyperexcitability but it is unclear what effects A{beta}-associated hyperexcitability may have on tauopathy pathogenesis or propagation in vivo. Using a novel transgenic mouse line to model the impact of hAPP/A{beta} accumulation on tauopathy in the entorhinal cortex-hippocampal (EC-HIPP) network, we demonstrate that hAPP aggravates EC tau aggregation and accelerates pathological tau spread into the hippocampus. In vivo recordings revealed a strong role for hAPP/A{beta}, but not tau, in the emergence of EC neuronal hyperactivity and impaired theta rhythmicity. Chemogenetic attenuation of A{beta}-associated hyperactivity led to reduced hAPP/A{beta} accumulation and reduction of pathological tau in downstream hippocampus. These data strongly support the hypothesis that in Alzheimers disease (AD), A{beta}-associated hyperactivity accelerates the progression of pathological tau along vulnerable neuronal circuits, and demonstrates the utility of chronic, neuromodulatory approaches in ameliorating AD pathology in vivo.
High-definition transcranial direct current stimulation over the dorsal premotor cortex reliably modulates motor network excitability
Authors: Lefebvre, S.; Jann, K.; Schmiesing, A.; Ito, K.; Jog, M.; Qiao, Y.; Cabeen, R.; Shi, Y.; Schweighofer, N.; Wang, D. J.; Liew, S.-L.
Category: neuroscience
Date: 2018-12-04

The effectiveness of transcranial direct current stimulation (tDCS) placed over the motor hotspot (thought to represent the primary motor cortex (M1)) to modulate motor network excitability is highly variable. The premotor cortex--particularly the dorsal premotor cortex (PMd)--may be a promising alternative target to more effectively modulate motor excitability, as it influences motor control across multiple pathways, one independent of M1 and one with direct, modulating connections to M1. This double-blind, placebo-controlled study aimed to differentially excite motor and premotor regions using high-definition tDCS (HD-tDCS) with concurrent functional magnetic resonance imaging (fMRI). HD-tDCS applied over either the motor hotspot or the premotor cortex demonstrated high inter-individual variability in changes on cortical motor excitability. However, HD-tDCS over the premotor cortex led to a higher number of responders and greater changes in local fMRI-based complexity than HD-tDCS over the motor hotspot. Furthermore, an analysis of individual motor hotspot anatomical locations revealed that, in more than half of the participants, the motor hotspot is not located over anatomical M1 boundaries, despite using a canonical definition of the motor hotspot. This heterogeneity in stimulation site may contribute to the variability of tDCS results. Altogether, these findings provide new considerations to enhance tDCS reliability.
Decreased grey matter volume in mTBI patients with post-traumatic headache compared to headache-free mTBI patients and healthy controls: a longitudinal MRI study
Authors: Burrowes, S. A. B.; Sours Rhodes, C.; Meeker, T. J.; Greenspan, J. D.; Gullapalli, R. P.; Seminowicz, D. A.
Category: neuroscience
Date: 2018-12-04

BackgroundTraumatic brain injury (TBI) occurs in 1.7 million people annually and many patients go on to develop persistent disorders including post-traumatic headache (PTH). PTH is considered chronic if it continues past 3 months. In this study we aimed to identify changes in cerebral grey matter volume (GMV) associated with PTH in mild TBI patients.\n\nMethods50 mTBI patients (31 Non-PTH; 19 PTH) underwent MRI scans: within 10 days post-injury, 1 month, 6 months and 18 months. PTH was assessed at visit 4 by a post-TBI headache questionnaire. Healthy controls (n=21) were scanned twice 6 months apart.\n\nResultsCompared to non-PTH, PTH patients had decreased GMV across two large clusters described as the right anterior-parietal (p=0.012) and left temporal-opercular (p=0.027). Compared to healthy controls non-PTH patients had decreased GMV in the left thalamus (p=0.047); PTH patients had decreased GMV in several extensive clusters: left temporal-opercular (p=0.003), temporal-parietal (p=0.041), superior frontal gyrus (p=0.008) and right middle frontal/superior frontal gyrus (0.004) and anterior-parietal (p=0.003).\n\nConclusionDifferences between PTH and non-PTH patients were most striking at early time points. These early changes may be associated with an increased risk of PTH. Patients with these changes should be monitored for chronic PTH.
Temporal patterns of fluoxetine-induced plasticity in the mouse visual cortex
Authors: Steinzeig, A.; Cannarozzo, C.; Castren, E.
Category: neuroscience
Date: 2018-12-04

Heightened neuronal plasticity expressed during early postnatal life has been thought to permanently decline once critical periods have ended. For example, monocular deprivation is able to shift ocular dominance in the mouse visual cortex during the first months of life, but this effect is lost later in life. However, various treatments such as the antidepressant fluoxetine can reactivate a critical period-like plasticity in the adult brain. When monocular deprivation is supplemented with chronic fluoxetine administration, a major shift in ocular dominance is produced after the critical period has ended. In the current study, we characterized the temporal patterns of fluoxetine-induced plasticity in the adult mouse visual cortex, using in vivo optical imaging. We found that artificially-induced plasticity in ocular dominance extended beyond the duration of the naturally occurring critical period, and continued as long as fluoxetine was administered. However, this fluoxetine-induced plasticity period ended as soon as the drug was not given. Taken together, our data highlights how a combination of pharmacological treatment and environmental change could be used to improve strategies in antidepressant therapy in humans.
Anatomical basis and physiological role of cerebrospinal fluid transport through the murine cribriform plate
Authors: Norwood, J. N.; Zhang, Q.; Card, D.; Craine, A.; Ryan, T. M.; Drew, P. J.
Category: neuroscience
Date: 2018-12-04

Cerebrospinal fluid (CSF) flows through the brain, transporting chemical signals and removing waste. CSF production in the brain is balanced by a constant outflow of CSF, the anatomical basis of which is poorly understood. Here we characterized the anatomy and physiological function of the CSF outflow pathway along the olfactory sensory nerves through the cribriform plate, and into the nasal epithelia. Chemical ablation of olfactory sensory nerves greatly reduced outflow of CSF through the cribriform plate. The reduction in CSF outflow did not cause an increase in intracranial pressure (ICP), consistent with an alteration in the pattern of CSF drainage or production. Our results suggest that damage to olfactory sensory neurons (such as from air pollution) could contribute to altered CSF turnover and flow, providing a potential mechanism for neurological diseases.
Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity
Authors: Klickovic, U.; Zampedri, L.; Sinclair, C.; Wastling, S.; Trimmel, K.; Howard, R.; Malaspina, A.; Sharma, N.; Sidle, K.; Emira, A.; Shah, S.; Yousry, T.; Hanna, M.; Greensmith, L.; Morrow, J.; Thornton, J.; Fratta, P.
Category: neuroscience
Date: 2018-12-04

ObjectiveTo investigate the use of muscle MRI for the differential diagnosis and as a disease progression biomarker for two major forms of motor neuron disorders, spinal bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS).\n\nMethodsWe applied quantitative 3-point Dixon and semi-quantitative T1-weighted and STIR imaging to bulbar and lower limb muscles and performed clinical and functional assessments in ALS (n=21) and SBMA (n=21) patients, alongside healthy controls (n=16). Acquired images were analyzed for the presence of fat infiltration or edema as well as specific patterns of muscle involvement. Quantitative MRI measurements were correlated with clinical parameters of disease severity in ALS and SBMA.\n\nResultsQuantitative imaging revealed significant fat infiltration in bulbar (p<0.001) and limb muscles in SBMA compared to controls (thigh: p<0.001; calf: p=0.001), identifying a characteristic pattern of muscle involvement. In ALS, semi-quantitative STIR imaging detected marked hyperintensities in lower limb muscles, distinguishing ALS from SBMA and controls. Lastly, MRI measurements correlated significantly with clinical scales of disease severity in both ALS and SBMA.\n\nConclusionsOur findings show that muscle MRI differentiates between SBMA and ALS and correlates with disease severity, supporting its use as a diagnostic tool and biomarker for disease progression. This highlights the clinical utility of muscle MRI in motor neuron disorders and contributes to establish objective outcome measures, which is crucial for the development of new drugs.
Auditory deviance detection in the human insula: An intracranial EEG study
Authors: Blenkmann, A. O.; Collavini, S.; Lubell, J.; Llorens, A.; Funderud, I.; Ivanovic, J.; Larson, P. G.; Meling, T. R.; Bekinschtein, T.; Kochen, S.; Endestad, T.; Knight, R. T.; Solbakk, A.-K.
Category: neuroscience
Date: 2018-12-04

While the human insula is known to be involved in auditory processing, knowledge about its precise functional role and the underlying electrophysiology is limited. To assess its role in automatic auditory deviance detection we analyzed the high frequency EEG activity (75-145 Hz) from 90 intracranial insular electrodes across 16 patients who were candidates for resective epilepsy surgery while they passively listened to a stream of standard and deviant tones. Deviant and standard tones differed in four physical dimensions: intensity, frequency, location and time. Auditory responses were found in the short and long gyri, and the anterior, superior, and inferior segments of the circular sulcus of the insular cortex, but only a subset of electrodes in the inferior segment showed deviance detection responses, i.e. a greater and later response to deviants relative to standards. Altogether, our results indicate that the human insula is engaged during auditory deviance detection.
Exenatide reverts the high-fat-diet-induced impairment of BDNF signaling and inflammatory response in an animal model of Alzheimer’s disease
Authors: Bomba, M.; Granzotto, A.; Castelli, V.; Lattanzio, R.; Cimini, A.; Sensi, S. L.
Category: neuroscience
Date: 2018-12-04

Backgroundpreclinical, clinical, and epidemiological evidence support the notion that Alzheimers disease(AD) is a multifactorial condition in which, along with {beta}-amyloid (A{beta}) and tau-related pathology, the synergistic activity of genetic, environmental, vascular, metabolic, and inflammatory factors promote the onset and progression of the disease. Epidemiological evidence indicate that glucose intolerance, deficits in insulin secretion or type 2 diabetes mellitus (T2DM) participate in increasing the risk of developing cognitive impairment or dementia. A pivotal role in the process is played by insulin as the hormone critically regulates brain functioning. GLP-1, the glucagon-like peptide 1, facilitates insulin signaling, regulates glucose homeostasis, and modulates synaptic plasticity. Exenatide is a GLP-1R agonist, characterized by an extended half-life, employed in T2DM. However, exenatide has also been shown to affect the signaling of the brain-derived neurotrophic factor (BDNF), synaptic plasticity, and cognitive performances in animal models of brain aging and neurodegeneration.\n\nMethodsin this study, we tested whether exenatide exerts neuroprotection in a preclinical AD model set to mimic the clinical complexity of the human disease. To that aim, we investigated the effects of 3-month exenatide treatment in 3xTg-AD mice challenged for six months with a high-fat diet (HFD). Endpoints of the study were variations in systemic metabolism, insulin and neurotrophic signaling, neuroinflammation, levels of A{beta} and tau pathology as well as changes in cognitive performances.\n\nFindings and interpretationresults of the study indicate that exenatide reverts the adverse changes of BDNF signaling and the neuroinflammation status of 3xTg-AD mice undergoing HFD.
Schizotypy-related magnetization of cortex in healthy adolescence is co-located with expression of schizophrenia risk genes
Authors: Romero-Garcia, R.; Seidlitz, J.; Whitaker, K. J.; Morgan, S. E.; Fonagy, P.; Dolan, R. J.; Jones, P. B.; Goodyer, I. M.; Suckling, J.; NSPN Consortium,  ; Vertes, P. E.; Bullmore, E. T.
Category: neuroscience
Date: 2018-12-04

BackgroundGenetic risk is thought to drive clinical variation on a spectrum of schizophrenia-like traits but the underlying changes in brain structure that mechanistically link genomic variation to schizotypal experience and behaviour are unclear.

MethodsWe assessed schizotypy using a self-reported questionnaire, and measured magnetization transfer (MT), as a putative micro-structural MRI marker of intra-cortical myelination, in 68 brain regions, in 248 healthy young people (aged 14-25 years). We used normative adult brain gene expression data, and partial least squares (PLS) analysis, to find the weighted gene expression pattern that was most co-located with the cortical map of schizotypy-related magnetization (SRM).

ResultsMagnetization was significantly correlated with schizotypy in bilateral posterior cingulate cortex and precuneus (and for disorganized schizotypy also in medial prefrontal cortex; all FDR-corrected P < 0.05), which are regions of the default mode network specialized for social and memory functions. The genes most positively weighted on the whole genome expression map co-located with SRM were enriched for genes that were significantly down-regulated in two prior case-control histological studies of brain gene expression in schizophrenia. Conversely, the most negatively weighted genes were enriched for genes that were transcriptionally up-regulated in schizophrenia. Positively weighted (down-regulated) genes were enriched for neuronal, specifically inter-neuronal, affiliations and coded a network of proteins comprising a few highly interactive "hubs" such as parvalbumin and calmodulin.

ConclusionsMicrostructural MRI maps of intracortical magnetization can be linked to both the behavioural traits of schizotypy and to prior histological data on dysregulated gene expression in schizophrenia.